Veracyte Stock Price on November 21, 2024
| VCYT Stock | USD 42.84 1.74 4.23% |
Below is the normalized historical share price chart for Veracyte extending back to October 30, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Veracyte stands at 42.84, as last reported on the 26th of November, with the highest price reaching 42.86 and the lowest price hitting 40.57 during the day.
If you're considering investing in Veracyte Stock, it is important to understand the factors that can impact its price. Veracyte appears to be very steady, given 3 months investment horizon. Veracyte owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had a 0.18% return per unit of risk over the last 3 months. By inspecting Veracyte's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please review Veracyte's Semi Deviation of 2.31, coefficient of variation of 656.67, and Risk Adjusted Performance of 0.1236 to confirm if our risk estimates are consistent with your expectations.
At this time, Veracyte's Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 86.9 K in 2024, whereas Capital Stock is likely to drop slightly above 66.9 K in 2024. . At this time, Veracyte's Price To Operating Cash Flows Ratio is comparatively stable compared to the past year. Price To Free Cash Flows Ratio is likely to gain to 61.25 in 2024, whereas Price Book Value Ratio is likely to drop 1.82 in 2024. Veracyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of October 2013 | 200 Day MA 26.3924 | 50 Day MA 34.8859 | Beta 1.668 |
Veracyte |
Sharpe Ratio = 0.1834
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VCYT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.8 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Veracyte is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Veracyte by adding it to a well-diversified portfolio.
Price Book 2.6089 | Enterprise Value Ebitda 163.2149 | Price Sales 7.4888 | Shares Float 77.2 M | Wall Street Target Price 42.7778 |
Related Headline
Crinetics Pharmaceuticals Headline on 21st of November 2024
Crinetics Pharmaceuticals, Inc. Receives Consensus Recommend... by thelincolnianonline.com
Shares of Crinetics Pharmaceuticals, Inc. have earned a consensus rating of Moderate Buy from the eleven ratings firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12-month price objective
Veracyte Valuation on November 21, 2024
It is possible to determine the worth of Veracyte on a given historical date. On November 21, 2024 Veracyte was worth 39.38 at the beginning of the trading date compared to the closed value of 38.94. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Veracyte stock. Still, in general, we apply an absolute valuation method to find Veracyte's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Veracyte where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Veracyte's related companies.
| Open | High | Low | Close | Volume | |
| 39.16 | 39.80 | 38.61 | 39.20 | 632,007 | |
11/21/2024 | 39.38 | 39.81 | 38.73 | 38.94 | 634,452 |
| 38.79 | 39.75 | 38.13 | 39.59 | 714,947 |
| Backtest Veracyte | | | Veracyte History | | | Veracyte Valuation | Previous | Next |
Veracyte Trading Date Momentum on November 21, 2024
| On November 22 2024 Veracyte was traded for 39.59 at the closing time. The top price for the day was 39.75 and the lowest listed price was 38.13 . The trading volume for the day was 714.9 K. The trading history from November 22, 2024 was a factor to the next trading day price appreciation. The trading price change against the next closing price was 1.67% . The trading price change against the current closing price is 4.98% . |
Veracyte Fundamentals Correlations and Trends
By evaluating Veracyte's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Veracyte's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Veracyte financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Veracyte Stock history
Veracyte investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Veracyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Veracyte will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Veracyte stock prices may prove useful in developing a viable investing in Veracyte
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 72.6 M | 41.6 M | |
| Net Loss | -32.9 M | -34.5 M |
Veracyte Quarterly Net Working Capital |
|
Veracyte Stock Technical Analysis
Veracyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Veracyte Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Veracyte cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Veracyte November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Veracyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Veracyte shares will generate the highest return on investment. By undertsting and applying Veracyte stock market strength indicators, traders can identify Veracyte entry and exit signals to maximize returns
Veracyte Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Veracyte's price direction in advance. Along with the technical and fundamental analysis of Veracyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Veracyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1236 | |||
| Jensen Alpha | 0.245 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.1101 | |||
| Treynor Ratio | 0.2986 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Veracyte Stock Analysis
When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.